
Monoclonal Antibodies and COVID-19: Insight from an Infectious Disease Expert
Monoclonal antibodies have been getting a lot of attention as a treatment for COVID-19. Monoclonal antibody infusion centers for COVID-19 patients are opening at Virginia Mason and across the country. But what exactly are monoclonal antibodies? How do they work and who needs them?

Why COVID-19 Makes It Harder to Predict This Year’s Flu Season
Before COVID-19, having the sniffles or a mild headache was rarely cause for concern. Now, it’s common practice to stay home at the first sign of a cold. This is one of the reasons that there was very low flu activity during last year's flu season. But will that trend continue this year?

Back to School with Type 1 Diabetes
The transition from elementary school to middle school is a big step for any kid. Multiple teachers instead of one, new letter grades, no recess. It’s a different world, especially when most of fifth grade took place at home because of the COVID-19 pandemic.

Meet Penny: A Goldendoodle Helping Her Teen Manage T1D
When Grace Pilo is in a ballet performance, she uses a continuous glucose monitor and insulin pump to make sure her blood sugar stays in a healthy range throughout the show.

How Does Wildfire Smoke Impact Your Health?
We’ve become hyper-aware of health hazards spread through the air, and that isn’t limited to infectious diseases like COVID-19. Another problem is becoming alarmingly commonplace: wildfire smoke.

Joining Research to Target T1D at the Source
It was the dead of the night in Brisbane, Australia. Maree Doolan, then a nurse, was in the middle of a long shift. “We were messing around and decided to take our blood sugars,” she says. “I was shocked that mine was quite high, in the 280 range.

TSLP: From Intriguing Protein to Groundbreaking Therapy
It’s the 1990s in Seattle. Grunge music is getting national play. Amazon operates out of a garage. And a mysterious protein catches the eye of Steve Ziegler, PhD.

The Current State of COVID-19: How Dangerous is Delta and Other Key Questions
At this point, we’ve lived through many phases of the pandemic: closing schools and sanitizing surfaces. Mask mandates and mRNA vaccines. Now, we’ve reached a new phase, with still more questions: How dangerous is the Delta variant?

Beyond Insulin: Beyond BRI's Quest to Stop Type 1 Diabetes
The discovery of insulin 100 years ago transformed type 1 diabetes (T1D) from a death sentence to a chronic illness. Yet T1D is still a relentless disease with no cure.

Understanding COVID-19 Vaccine Response: New Studies for Autoimmune Disease and Down Syndrome
Throughout the pandemic, Cate Speake, PhD, and the Center for Interventional Immunology have conducted countless COVID-19 studies — from understanding how the immune system responds to the virus to testing the Pfizer vaccine.